Extension Study: Evaluating the Safety of Oral Ziprasidone in the Treatment of Subjects With Schizophrenia
Clinical trial NCT00139737 · COMPLETED
Trial details
- NCT number
- NCT00139737
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-03-01
- Primary completion
- 2009-06-01
- Enrollment
- 344
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.